NCT00642148 - A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

306

Participants

Timeline

Start Date

February 14, 2008

Primary Completion Date

July 27, 2009

Study Completion Date

July 27, 2009

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GW856553

Active tablet

DRUG

Placebo

Placebo tablet and inhaler

DRUG

Seretide

Active comparator inhaler

Trial Locations (31)

1000

GSK Investigational Site, Ljubljana

1005

GSK Investigational Site, Auckland

1241

GSK Investigational Site, Kamnik

4126

GSK Investigational Site, eManzimtoti

6035

GSK Investigational Site, Wellington

7505

GSK Investigational Site, Cape Town

7700

GSK Investigational Site, Mowbray

10717

GSK Investigational Site, Berlin

13419

GSK Investigational Site, Tallinn

22927

GSK Investigational Site, Großhansdorf

23552

GSK Investigational Site, Lübeck

39112

GSK Investigational Site, Magdeburg

51014

GSK Investigational Site, Tartu

55131

GSK Investigational Site, Mainz

82131

GSK Investigational Site, Gauting

194044

GSK Investigational Site, Saint Petersburg

00290

GSK Investigational Site, Helsinki

LV1002

GSK Investigational Site, Riga

LT-92231

GSK Investigational Site, Klaipėda

4819 EV

GSK Investigational Site, Breda

6419 PC

GSK Investigational Site, Heerlen

5504 DB

GSK Investigational Site, Veldhoven

656 045

GSK Investigational Site, Barnaul

105 229

GSK Investigational Site, Moscow

197 089

GSK Investigational Site, Saint Petersburg

120-752

GSK Investigational Site, Seoul

136-705

GSK Investigational Site, Seoul

137-701

GSK Investigational Site, Seoul

OX3 7LJ

GSK Investigational Site, Headington

HU16 5JQ

GSK Investigational Site, Cottingham, East Yorkshire

E2 9JX

GSK Investigational Site, London